Abstract:10-Hydroxycamptothecin (HCPT) is insoluble in both water and physiological acceptable organic solvents and tends to change into its carboxylate form, which shows minimal anticancer activity and several unpredictable side effects. The goal of this study is to exploit an appropriate delivery system for HCPT to improve the stability of its lactone form. Bovine serum albumin (BSA) nanoparticles entrapping HCPT were prepared by reformative emulsion-heat stabilization technique. During this process, HCPT transformed from lactone to carboxylate and finally back to lactone form successfully. A simple reversed-phased HPLC method was developed to analyze both lactone and carboxylate forms of HCPT synchronously. Mean particle size and the ratio of lactone and carboxylate forms of HCPT were evaluated to investigate the effects of the formulations and preparation conditions. It was indicated the percentage of lactone form of HCPT in resultant BSA nanoparticles could be improved over 95% through adjusting the concentration of NaOH solution and the stirring time after high-speed emulsification. This drug delivery system was also characterized by dynamic light scattering (DLS) and light microscopy. The investigations on drug loading, in vitro release and body distribution in rats after intravenous (i.v.) administration were also carried out. It was found that the obtained nanoparticles showed spherical shape with the mean particle size of around 600 nm, and drug loading content, encapsulation efficiency and yield achieved 2.21%, 57.5% and 90.5% with the optimal preparation conditions, respectively. The in vitro release behavior exhibited a sustaining release manner and was affected by the trypsin in medium. HCPT could release more than 90% within 20 h in the medium of pH 7.4 PBS containing 750 U/ml trypsin, but only 25% within 40 h in the pure pH 7.4 PBS. The results of body distribution study in rats showed the liver targeting potential of HCPT-BSA nanoparticles that 59.6%, 52.9% and 55.3% of the examined amount of lactone HCPT accumulated in livers at 1, 4 and 24h after injection, respectively. These results suggest that the HCPT-BSA nanoparticles seem to be a stable delivery system for poorly soluble HCPT or its derivatives.

Preparation and Rats' Pharmacokinetics of TM208 HP-β-CD Inclusion Complexes

LC and LC–MS Study of the Bioavailability and Metabolites of TM208 after Oral and Intravenous Administration to Rat

Studies on the Metabolism of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride in Rats by High-Performance Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry

Analysis of 4-Methyl-piperazine-1-carbodithioic Acid 3-Cyano-3,3-diphenyl-propyl Ester Hydrochloride and Its Major Metabolites in Rat Plasma and Tissues by LC-MS/MS.

Studies on the Metabolism of 4-Methylpiperazine-1-carbodithioc Acid 3-Cyano-3,3- Diphenylpropyl Ester Hydrochloride in Rat Bile by High-Performance Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry.

Enhanced Antitumor Effect of TM208 in Combination with 5-Fluorouracil in H22 Transplanted Mice

Metabonomic Analysis of the Toxic Effects of TM208 in Rat Urine by HPLC-ESI-IT-TOF/MS.

Analysis of hydrochloride 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3,3-diphenyl-propyl ester and its metabolites in rats by HPLC-ESI/ITMSn]

Determination of Anti-Tumor Agent TM208, 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride, in Rats by LC

A High-Sensitivity Lc-Ms/Ms Method for the Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3, 3-Diphenylpropyl Ester Hydrochloride in Rat Plasma and Its Application to A Pharmacokinetics Study

Simultaneous Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride and Its Major Metabolite in Rats by Hplc

Effect of TM208 on QGY-7703 xenograft tumor growth.

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

[Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].

Complex of 9-nitro-camptothecin in hydroxypropyl-β-cyclodextrin: In vitro and in vivo evaluation

Preparation of tilmicosin-resin complex microsphere and its Pharmacokinetics study in rat

Preparation, Characterization and Pharmacokinetics of 10-Hydroxy-camptothecin Nanosuspension

Preparation of Tc-carbonyl Complexes of Tryptophan and Histidine and Biodistribution in Mice Bearing S180 Tumor

Inhibition of EGFR Autophosphorylation Plays an Important Role in the Anti-Breast Cancer Efficacy of the Dithiocarbamate Derivative TM208

Identification of the metabolite and cytochrome P450 isoenzymes involved in the rat liver microsomal metabolism of TM208

Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles